274
Participants
Start Date
May 23, 2019
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2025
DAS181
DAS181 4.5mg nebulized qd x 7 OR 10 days
Placebo
Placebo nebulized qd x 7 OR 10 days
DAS181 COVID-19
DAS181 4.5mg nebulized q12h/day x 7 OR 10 days
DAS181 OL
DAS181 4.5mg nebulized qd x 7 OR 10 days ≥ 40kg DAS181 2.5mg nebulized qd x 7 OR 10 days \< 40kg
TERMINATED
Rigshospitalet, Copenhagen
TERMINATED
Westmead Hospital, Sydney
TERMINATED
Peter MacCallum Cancer Centre, Melbourne
TERMINATED
Royal Melbourne Hospital, Melbourne
TERMINATED
The Wesley Hospital, Auchenflower
TERMINATED
National Taiwan University Hospital, Zhongzheng
WITHDRAWN
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Weill Cornell Medical College, New York
TERMINATED
Seoul National University Bundang Hospital, Seongnam-si
RECRUITING
University of Pittsburgh Medical Center Health System, Pittsburgh
WITHDRAWN
University of Pennsylvania, Philadelphia
WITHDRAWN
University of Maryland, Baltimore
WITHDRAWN
The Johns Hopkins Hospital, Baltimore
RECRUITING
VCU Health System, Richmond
WITHDRAWN
Novant Health, Winston-Salem
RECRUITING
Duke University, Durham
RECRUITING
Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami
WITHDRAWN
Houston Methodist Hospital, Tampa
WITHDRAWN
Vanderbilt University Medical Center, Nashville
WITHDRAWN
The Cleveland Clinic Foundation, Cleveland
WITHDRAWN
St. Elizabeth Youngstown Hospital, Youngstown
WITHDRAWN
The Lindner Center- The Christ Hospital, Cincinnati
RECRUITING
Cincinnati Children's Hospital Medical Center, Cincinnati
WITHDRAWN
University of Cincinnati, Cincinnati
WITHDRAWN
Universtiy of Michigan, Ann Arbor
RECRUITING
University of Iowa Health Care, Iowa City
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Froedtert Medical College Pulmonary Clinic, Milwaukee
RECRUITING
Mayo Clinic Rochester, Rochester
WITHDRAWN
Loyola University Medical Center, Maywood
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
WITHDRAWN
University of Chicago, Chicago
WITHDRAWN
Washington University, St Louis
RECRUITING
University of Kansas Medical Center, Fairway
WITHDRAWN
University of Nebraska Medical Center, Omaha
COMPLETED
Louisiana State University, Shreveport
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
RECRUITING
UT Southwestern Medical Center, Dallas
TERMINATED
Cook Children's, Fort Worth
COMPLETED
Texas Health, Fort Worth
COMPLETED
Therapeutic Concepts, Houston
RECRUITING
Baylor College of Medicine, Houston
WITHDRAWN
Houston Methodist Hospital, Houston
RECRUITING
MD Anderson, Houston
WITHDRAWN
Children's Hospital Colorado, Aurora
ACTIVE_NOT_RECRUITING
UCLA, Los Angeles
RECRUITING
City of Hope cancer Center, Duarte
WITHDRAWN
University of California San Diego Medical Center, San Diego
TERMINATED
Hôpital Henri Mondor, Créteil
RECRUITING
University of California Davis Health System, Sacramento
WITHDRAWN
Oregon Health & Science University, Portland
RECRUITING
Seattle Children's Hospital, Seattle
RECRUITING
Fred Hutchinson Cancer Center, Seattle
RECRUITING
Fred Hutchinson Cancer Research Center, Seattle
TERMINATED
Shanghai Pulmonary Hospital, Yangpu
TERMINATED
West China Hospital, Chengdu
RECRUITING
Brigham and Women's Hospital, Boston
WITHDRAWN
Beth Israel Deaconess Medical Center, Boston
COMPLETED
Kent Hospital, Warwick
TERMINATED
Shulan (Hangzhou) Hospital co., LTD, Hangzhou
TERMINATED
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
TERMINATED
Prince of Wales Hospital, Shatin
TERMINATED
National Cheng Kung University Hospital, Tainan City
TERMINATED
Seoul National University Hospital, Seoul
TERMINATED
Asan Medical Center, Seoul
TERMINATED
Samsung Medical Center, Seoul
TERMINATED
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Lead Sponsor
Ansun Biopharma, Inc.
INDUSTRY